Genetically modified autologous hematopoietic stem cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically modified autologous hematopoietic stem cell therapy, covering 2025-03-30 to 2025-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type IIIA [Phase 1, Phase 2]